Malaysia recently approved the Sinovac CoronaVac vaccine for use in adolescents!
Here is what you need to know!
Malaysia Approves Sinovac Vaccine For Use In Adolescents!
On 1 October 2021, the Malaysia Health Ministry (KKM) announced the Drug Control Authority (DCA) has approved the use of the Sinovac CoronaVac vaccine in adolescents 12-17 years in age.
However, the Drug Control Authority recommends that when it comes to adolescents 12 to 17 years old, the Sinovac vaccine should be used for :
- those without co-morbidities,
- those who have severe allergies, or
- those who are unable to take the Pfizer Comirnaty vaccine.
They will only determine if adolescents with co-morbidities are allowed to receive the Sinovac vaccine once there is sufficient data.
Sinovac COVID-19 Vaccine : A Quick Primer!
Sinovac CoronaVac an inactivated virus vaccine made from actual SARS-CoV-2 virus grown in Vero cells, and killed using β-propiolactone.
Developed by Sinovac Life Sciences, CoronaVac is a 2-dose inactivated virus vaccine, where the second dose delivered 14 days after the first.
Once injected into the body, the antigens on the inactivated SARS-CoV-2 virus triggers the body’s immune system.
Unlike the Pfizer and Moderna mRNA vaccines, CoronaVac only needs to be refrigerated at 2–8 °C (36–46 °F), which makes it easy to distribute.
On 6 February 2021, China approved the CoronaVac vaccine for general use.
Recommended : CoronaVac Vaccine By Sinovac : Your Questions Answered!
- National Recovery Plan Phase 3 SOP : 4 October Edition!
- Why Did Boy Collapse After Getting Pfizer COVID-19 Vaccine?
- Did 5 Teenagers Die From COVID-19 Vaccine?
- KKM Requirements To Accompany Wife During Delivery!
- Why Viral COVID-19 Advice By Dr. Leong Hoe Nam Is Fake!
- Why Dr. Pierre Kory Got COVID-19 Despite Taking Ivermectin!
If you like our work, please support us by visiting our sponsors, or donating to our fund. Thank you!